-
effectivehealthcare.ahrq.gov/health-topics/statins
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_executive.pdf
September 01, 2009 - Evidence comparing various doses of statin-
ezetimibe, statin-fibrate, statin-niacin, and statin-BAS … , statin-BAS, and statin-
omega-3 combinations. … , statin-BAS, and statin-omega-3 combinations. … the statin-fibrate, statin-niacin, statin-BAS,
and statin-omega-3 combinations with respect to statin … statin-niacin, and statin-omega-3 combinations.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_disposition-comments.pdf
September 01, 2014 - We agree that new trials with statin mono vs. statin + “add on” combo agent
(e.g., ACCORD, AIM HIGH) … Statin/niacin vs statin/EZE: fewer adverse cardiac events with
statin/niacin v statin/EZE (Taylor 2009 … statin combo therapies. … lower incidence of major cardiovascular events with statin+niacin than
with statin+ezetimibe. … as a
potent statin alone.
-
effectivehealthcare.ahrq.gov/sites/default/files/s143.pdf
October 01, 2007 - We identified statin initiators and those eligible for
statin initiation (based on having a physician … RESULTS
There was an average of 504 (�60.0) statin initiators and
8090 (�1168) statin noninitiators … Statin Initiators and Randomly* Selected
Comparators
No. … Statin Initiators and Matched Comparators
(Reduced Model)
No. … Statin Initiators and Comparators (Expanded
Model)
No.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_executive.pdf
February 01, 2014 - doses of statin could be used. … monotherapy, which
enabled us to synthesize data across statin type and statin
dose. … Included studies of fibrates + statin.
Included studies of niacin + statin. … statin potency. … therapy with omega-3 fatty acid and statin to
intensification of statin monotherapy.
-
effectivehealthcare.ahrq.gov/sites/default/files/s131.pdf
October 01, 2007 - On each statin user’s index date, we sampled a subject
who had not used a statin as of that date (ie, … on a statin)
and prevalent users (ie, those taking a statin for some time). … Cohort 1—Incident Statin Users and Nonusers
Cohort 1a—Incident statin users and nonusers matched on … We restricted cohort 1 to incident statin users,
defined as no statin use in the 12 months before the … Thirty-six percent of incident statin users and 22.5%
of prevalent users stopped taking their statin.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/high-cholestorol-medicines-update_research-protocol.pdf
December 31, 2013 - type, and statin dose. … inhibitor (statin)
Lovastatin Mevacor® Oral HMG-CoA reductase inhibitor (statin)
Pitavastatin Livalo … +
ezetimibe vs. statin monotherapy; statin + nicotinic acid vs. statin monotherapy). … Our comparison of a lower
dose statin in combination therapy with higher dose statin monotherapy will … be statin
specific.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_disposition-comments.pdf
March 10, 2010 - , the equipoise is whether to add
another non-statin drug vs. to change to a more potent statin … this … had multiple statin
arms. … doses that are closer/equal to the
statin (i.e. statin) in the other arm will be used for dose-non … combination versus
statin monotherapy." … to the same dose of statin plus ezetimibe.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_executive.pdf
October 01, 2015 - to intravenous saline, 4 comparing
a statin plus N-acetylcysteine to N-acetylcysteine, and 6
other … comparisons of statin versus statin, statin by dose, or
statins plus other agents); 5 RCTs (N = 3,647 … Statins
The SOE was moderate in studies that compared use of
a statin plus intravenous fluids versus … fluids
alone, showing a clinically important and statistically
significant reduction in CIN with statin … in
patients receiving LOCM or IOCM, the best evidence
of potential benefit was seen with use of a statin
-
effectivehealthcare.ahrq.gov/products/high-cholestorol-medicines-update/research
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_surveillance.pdf
January 01, 2013 - The mean SBP was
significantly lowered in the supplement-
statin combination group (grade: low) in … Effect of n-3 fatty acids and
statins on oxidative stress in statin-treated
hypercholestorelemic and … Efficacy and safety of eicosapentaenoic
acid ethyl ester (AMR101) therapy in statin-
treated patients … Vascepa had greater TG-lowering
effects on those with higher-
efficacy statin regimens and/or
higher … Inclusion criteria: diabetes
or hypercholesterolemia
under statin treatment, and
at least 1 of the
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_executive.pdf
April 01, 2012 - In three short-term efficacy trials of omega-3
fatty acid and statin coadministration, statin adherence … The mean SBP was
significantly lowered in the supplement-statin combination
group (grade: low) in 22 … One RCT of 32 participants with statin-induced myopathic
symptoms89 found a significantly greater number … However, a significantly elevated fasting blood
glucose in the omega-3 fatty acids plus statin group … Evidence regarding benefit
of coenzyme Q10 in reducing myalgia in participants
with statin-induced
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/dot-plots-methods.pdf
October 01, 2021 - Dot plot for dichotomous outcomes, statins versus placebo or no statin ........................ 3
Figure … focused on
dichotomous outcomes; for the pilot we used pooled data for statins versus placebo or no statin … Dot plot for dichotomous outcomes, statins versus placebo or no statin
Abbreviations: AE = adverse
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/dot-plots-methods.pdf
October 01, 2021 - Dot plot for dichotomous outcomes, statins versus placebo or no statin ........................ 3
Figure … focused on
dichotomous outcomes; for the pilot we used pooled data for statins versus placebo or no statin … Dot plot for dichotomous outcomes, statins versus placebo or no statin
Abbreviations: AE = adverse
-
effectivehealthcare.ahrq.gov/sites/default/files/communicating_risk_international_king.ppt
January 01, 2005 - What do we know about how evidence of harm and benefit is communicated in other countries?
What do we know about how evidence of harm and benefit is communicated in other countries?
Valerie King MD, MPH and David Hickam MD, MPH
John M. Eisenberg Clinical Decisions and Communications Science Center
Oregon Health &…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND__0250_05-20-2010.pdf
January 01, 2010 - Effective Health Care
Topic Number(s): 0268a-b-c
Document Completion Date: 02-25-11
1
Results of Topic Selection Process & Next Steps
Treatment of atrial fibrillation (AF) and stroke prevention in AF will go forward for refinement as
systematic reviews. Primary prevention of AF will not go f…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_disposition-comments.pdf
January 07, 2016 - Thank you for your comment
49 Technical
Expert #3
Results Results: Statin section: Although the … section you report the statin doses used in trials but don't tell me the drug. … A new analysis has been added to the statin
section comparing statin plus NAC v NAC
alone. … As I understand, statin trials were conducted in a specific population. … The included studies are on subjects who are
statin naive.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/observational-research-scores_research.pdf
May 01, 2012 - The rarity of
rhabdomyolysis (estimated incidence 0.4-6.0 per 10,000 person-years among statin users … However, an observational study of rhabdomyolysis among rosuvastatin and other statin users is
also … Since LDL level is a primary indication for statin therapy and higher
LDL levels are anticipated to … Table 4 shows the effect of matching on
the statin statistics. … A propensity score−matched cohort study of the effect of
statin, mainly fluvastatin, on the occurrence
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_executive.pdf
January 01, 2012 - No statin trials reported clinical outcomes data for
patients with albuminuria. … - In RCTs that compared high- versus low-dose
treatment (ARB, statin), strict versus standard
control … creatinine clearance, screening
such patients for impaired eGFR could lead to early
initiation of statin … Statin vs. statin (high
vs. low dose)
2 trials; 4,793
patients
Mortality: low
ESRD: insufficient … Effectiveness of statin
therapy in adults with coronary heart disease.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/nephropathy-contrast-induced_clinician.pdf
August 01, 2016 - e One study included in this meta-analysis compared a statin + sodium
bicarbonate + IV saline versus